A novel expression system based on coinfection of cells with two recombinant vaccinia viruses has been developed. One recombinant vaccinia virus contained the bacteriophage T7 RNA polymerase gene under control of a vaccinia virus promoter. The second recombinant vaccinia virus contained a target gene of choice flanked by bacteriophage T7 promoter and termination sequences. Maximum expression of the target gene occurred when cells were infected with 10 PFU of each recombinant virus. Although T7 RNA polymerase synthesis began shortly after infection, the target gene was not expressed until late times and was largely inhibited when DNA replication was blocked. Target gene transcripts were analyzed by agarose gel electrophoresis and had the predicted size. With this system, Escherichia coli (-galactosidase, hepatitis B virus surface antigen, and human immunodeficiency virus envelope proteins were made. In each case, the level of synthesis was greater than had previously been obtained with the more conventional recombinant vaccinia virus expression system. Molecular cloning vectors have been developed that allow expression of heterologous genes in procaryotic and eucaryotic cells. Genetic elements carried by these vectors typically confer drug resistance, ability to replicate autonomously, and regulatory controlling elements juxtaposed to the target gene of interest. While this approach has been extensively used in bacterial and mammalian cell expression systems, certain features of one system may be advantageous over another. Bacteria are easy to use and high expression is often attainable, but synthesis of native eucaryotic proteins is frequently not achieved. Mammalian cells can faithfully express eucaryotic proteins, but usually at relatively low levels. An expression system that used procaryotic transcriptional elements in mammalian cells might have important advantages since the catalytic activity, induciblity, and promoter specificity are well characterized.For these reasons, a chimeric expression system that used favorable transcriptional components from bacteria in a eucaryotic milieu may offer a highly specific and efficient method for the synthesis of ecuaryotic proteins.A eucaryotic transient-expression system based on a recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase in the cytoplasm of infected cells was recently described (5). Plasmids containing the target genes flanked by T7 promoter and termination sequences were introduced into infected cells by transfection procedures. The efficiency of the vaccinia virus-T7 transient system relative to that of more conventional mammalian transient expression systems was attributed to the high catalytic activity of T7 RNA polymerase and stringent T7 promoter specificity. Since it is possible to infect tissue culture cells synchronously with vaccinia virus, the absolute level of expression was probably limited by transfection of the target gene. It would seem that the efficiency of the system would be enhanced if vaccinia virus were used...